Diabetology and metabolic syndrome

Visão geral
Metrics
Identidade
Informação adicional documento
Ver todos

Qualis

A4

código do país

GB

tipo

journal

publicação venue de

'Proteomics of high-density lipoprotein subfractions and subclinical atherosclerosis in type 1 diabetes mellitus: a case-control study. 15:1. 2023-01-01
2022 - POSITION OF BRAZILIAN DIABETES SOCIETY ON EXERCISE RECOMMENDATIONS FOR PEOPLE WITH TYPE 1 and TYPE 2 DIABETES. 15:1-20. 2023-01-01
2022: Positi on of BrazilianDiabetes Society on Exercise Recommendations for People with Type 1 and 2 Diabetes. 15:1-20. 2023-01-01
2023 UPDATE: Luso-Brazilian evidence-based guideline for the management of antidiabetic therapy in type 2 diabetes. 15:1-37. 2023-01-01
Effects of Roux-en-Y gastric bypass on the metabolic profile and systemic inflammatory status of women with metabolic syndrome: randomized controlled clinical trial. 15:19-12. 2023-01-01
Increased risk of death following recurrent ketoacidosis admissions: a Brazilian cohort study of young adults with type 1 diabetes. 15:85-85. 2023-01-01
Islet transplantation: overcoming the organ shortage. 15:144-X. 2023-01-01
Levels and correlates of risk factor control in diabetes mellitus -ELSA-Brasil. 15:1-10. 2023-01-01
Position statement on nutrition therapy for overweight and obesity: nutrition department of the Brazilian association for the study of obesity and metabolic syndrome (ABESO-2022). 15:124. 2023-01-01
Prevalence of diabetic retinopathy in Brazil: a systematic review with meta-analysis. 15:34-38. 2023-01-01
Prevalence of overweight/obesity and its relationship with metabolic syndrome and fatty liver index in adult patients with type 1 diabetes. A Brazilian multicenter study. 15:1-28. 2023-01-01
Residual β-cell function in Brazilian Type 1 diabetes after 3 years of diagnosis: prevalence and association with low presence of nephropathy. 15:51-51. 2023-01-01
The impact of patient navigation on glycemic control, adherence to self-care and knowledge about diabetes: an intervention study. 15:1-178. 2023-01-01
The performance of the MODY calculator in a non-Caucasian, mixed-race population diagnosed with diabetes mellitus before 35 years of age. 15:1-15. 2023-01-01
The safety of SGLT-2 inhibitors in diabetic patients submitted to elective percutaneous coronary intervention regarding kidney function: SAFE-PCI pilot study. 15:1-8. 2023-01-01
Biochemical and clinical markers of endothelial dysfunction do not outweigh traditional risk factors for the presence of diabetic retinopathy in patients with type 1 diabetes. 14:141-144. 2022-01-01
Clinical and humanistic impact of pharmacotherapeutic follow-up in patients with type 1 diabetes mellitus treated judicially. 14:1-10. 2022-01-01
Comparison of three insulin bolus calculators to increase time in range of glycemia in a group of poorly controlled adults Type 1 diabetes in a Brazilian public health service. 14:129. 2022-01-01
Contemporary (2019) prevalence of cardiovascular disease in adults with type 2 diabetes in Brazil: the cross-sectional CAPTURE study. 14:1-9. 2022-01-01
Fatty acids composition and in vivo biochemical effects of Aleurites moluccana seed (Candlenut) in obese wistar rats. 14:.-.. 2022-01-01
Health-related quality of life in T1DM patients after high-dose cholecalciferol supplementation: data from a pilot clinical trial. 14:1-5. 2022-01-01
Hospital management of hyperglycemia in the context of COVID-19: evidence-based clinical considerations. 14:37. 2022-01-01
Increased serum IL-6 is predictive of long-term cardiovascular events in high-risk patients submitted to coronary angiography: an observational study. 14:125. 2022-01-01
NT-proBNP as a predictor of death and cardiovascular events in patients with type 2 diabetes. 14:64. 2022-01-01
Overt diabetes imposes a comparable burden on outcomes as pregestational diabetes: a cohort study. 14:177. 2022-01-01
Overweight/obesity in adolescents with type 1 diabetes belonging to an admixed population. A Brazilian multicenter study. 14:1-6. 2022-01-01
Quality of care in patients with type 1 diabetes during the COVID‑19 pandemic: a cohort study from Southern Brazil. 14:1-8. 2022-01-01
Reduced gut microbiota diversity in patients with congenital generalized lipodystrophy. 14:1-12. 2022-01-01
Risk factors for cognitive decline in type 2 diabetes mellitus patients in Brazil: a prospective observational study. 14:1-13. 2022-01-01
The 2021-2022 position of Brazilian Diabetes Society on diabetic kidney disease (DKD) management: an evidence-based guideline to clinical practice. Screening and treatment of hyperglycemia, arterial hypertension, and dyslipidemia in the patient with DKD. 14:1-28. 2022-01-01
The 2021?2022 position of Brazilian Diabetes Society on insulin therapy in type 1 diabetes: an evidence-based guideline to clinical practice. 14:1-9. 2022-01-01
The effectiveness of the use of telehealth programs in the care of individuals with hypertension and, or diabetes mellitus: systematic review and meta-analysis.. 1:1-14. 2022-01-01
The gut microbiome of obese postpartum women with and without previous gestational diabetes mellitus and the gut microbiota of their babies. 14:1-194. 2022-01-01
Advances in GLP-1 treatment: focus on oral semaglutide. 13:99. 2021-01-01
Bariatric surgery can acutely modulate ER-stress and inflammation on subcutaneous adipose tissue in non-diabetic patients with obesity. 13:1-11. 2021-01-01
Cross-national comparison of psychosocial well-being and diabetes outcomes in adults with type 1 diabetes during the COVID-19 pandemic in US, Brazil, and Iran. 13:13:63-74. 2021-01-01
Diabetes self-care practices and resilience in the Brazilian COVID-19 pandemic: results of a web survey: DIABETESvid. 13:1-4. 2021-01-01
Diabetes, obesity, and insulin resistance in COVID-19: molecular interrelationship and therapeutic implications. 13:1-14. 2021-01-01
Diet-induced obesity in animal models: points to consider and influence on metabolic markers. 13:1-11. 2021-01-01
Diet-induced obesity in animal models: points to consider and infuence on metabolic markers. 13:1-1. 2021-01-01
Dose-response effect of prebiotic ingestion (β-glucans isolated from Saccharomyces cerevisiae) in diabetic rats with periodontal disease. 13:1-1. 2021-01-01
Exploring early combination strategy in Latin American patients with newly diagnosed type 2 diabetes: a sub-analysis of the VERIFY study. 13:68. 2021-01-01
Human Leukocyte Antigens class II (HLA II) gene profile from an admixed population of patients with type 1 diabetes with severe diabetic retinopathy: a nested case-control study in Brazil. 13:1-8. 2021-01-01
Insulin resistance and associated factors in female adolescents from two capital cities in the north and south of Brazil Poli Mara Spritzer. 13:1-114. 2021-01-01
Metabolic profile of women with PCOS in Brazil: a systematic review and meta-analysis. 13:1-16. 2021-01-01
Outcome and death risk of diabetes patients with Covid-19 receiving pre-hospital and in-hospital metformin therapies. 13:76-88. 2021-01-01
Oxidative phenotype induced by aerobic physical training prevents the obesity-linked insulin resistance without changes in gastrocnemius muscle ACE2-Angiotensin(1-7)-Mas axis. 13:1-11. 2021-01-01
Pens versus syringes to deliver insulin among elderly patients with type 2 diabetes: a randomized controlled clinical trial. 13:1. 2021-01-01
Prevalence of non-alcoholic fatty liver disease and its associated factors in individuals with type 1 diabetes: a cross-sectional study in a tertiary care center in Brazil. 13:1-11. 2021-01-01
Protection of coenzyme Q10 against contrast-induced acute kidney injury in male diabetic rats. 13:1-69. 2021-01-01
SARS-COV-2 infection outcomes in patients with congenital generalized lipodystrophy. 13:1-9. 2021-01-01
Use of continuous glucose monitoring system in patients with type 2 mellitus diabetic during hemodialysis treatment. 13:104. 2021-01-01
Using trend arrows in continuous glucose monitoring systems for insulin adjustment in clinical practice: Brazilian Diabetes Society Position Statement. 13:1-10. 2021-01-01
Cardiometabolic risk factors correlated with the incidence of dysglycaemia in a Brazilian normoglycaemic sample: the Baependi Heart Study cohort. 1:(2020) 12:6-7. 2020-01-01
Coronavirus infection (SARS-CoV-2) in obesity and diabetes comorbidities: is heat shock response determinant for the disease complications?. 12:1-10. 2020-01-01
Correlation between biomechanical changes, plantar pressure and balance of people with diabetic neuropathy. 11:P57-65. 2020-01-01
Dexamethasone in the era of COVID-19: friend or foe? An essay on the effects of dexamethasone and the potential risks of its inadvertent use in patients with diabetes. 12:80-85. 2020-01-01
Glomerular filtration rate estimated by the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation in type 1 diabetes based on genomic ancestry. 12:1-7. 2020-01-01
HbA1c variability and long-term glycemic control are linked to peripheral neuropathy in patients with type 1 diabetes. 12:12:85-85. 2020-01-01
Health literacy and glycemic control in patients with diabetes: a tertiary care center study in Brazil. 12:1-19. 2020-01-01
High anxiety and depressive symptoms in partners of type 1 diabetes persons in a sample of the Brazilian population. 12:1-26. 2020-01-01
Hypoglycemia symptoms and awareness of hypoglycemia in type 1 diabetes mellitus: cross-cultural adaptation and validation of the Portuguese version of three questionnaires and evaluation of its risk factors. 12:15. 2020-01-01
Increased leukotriene B4 plasma concentration in type 2 diabetes individuals with cardiovascular autonomic neuropathy. 12:1-1. 2020-01-01
Is it possible to substitute the monofilament test for the Ipswich Touch Test in screening for peripheral diabetic neuropathy?. 12:12-27. 2020-01-01
Leu124Serfs*26, a novel AGPAT2 mutation in congenital generalized lipodystrophy with early cardiovascular complications. 12:1-9. 2020-01-01
Maternal factors associated with hyperglycemia in pregnancy and perinatal outcomes: a Brazilian reference center cohort study. 12:1. 2020-01-01
Melatonin deficiency decreases brown adipose tissue acute thermogenic capacity of in rats measured by 18F-FDG PET.. 12:1-7. 2020-01-01
Mental health in the Era of COVID-19: Prevalence of Psychiatric Disorders in a Cohort of Patients with Type 1 and Type 2 Diabetes during the Social Distancing. 12:1-81. 2020-01-01
NAFLD as a continuum: from obesity to metabolic syndrome and diabetes. 12:32684985. 2020-01-01
Night shift work, short sleep and obesity. 12:01-09. 2020-01-01
Portuguese-Brazilian evidence-based guideline on the management of hyperglycemia in type 2 diabetes mellitus. 12:1-30. 2020-01-01
Prevalence of people at risk of developing type 2 diabetes mellitus and the involvement of community pharmacies in a national screening campaign: a pioneer action in Brazil. 12:1-100. 2020-01-01
Probiotics supplementation and insulin resistance: a systematic review. 12:98. 2020-01-01
Real-world flash glucose monitoring in Brazil: can sensors make a difference in diabetes management in developing countries?. 12:1-7. 2020-01-01
Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: a meta-analysis. 12:12. 2020-01-01
Short and long term effect of treatment non-pharmacological and lifestyle in patients with metabolic syndrome. 12:1-1. 2020-01-01
Therapeutic effects of different doses of prebiotic (isolated from Saccharomyces cerevisiae) in comparison to n-3 supplement on glycemic control, lipid profiles and immunological response in diabetic rats. 12:00-00. 2020-01-01
Time in range: a new parameter to evaluate blood glucose control in patients with diabetes. 12:1-22. 2020-01-01
Update on clinical screening of maturity-onset diabetes of the young (MODY). 12:50. 2020-01-01

tem uma área de assunto

publisher

Springer Science+Business Media

is open access

True invalid format

is in DOAJ

True invalid format